Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px

News > All

Total search results: 9941 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 98 99 100

order ascendingorder descendingSource order ascendingorder descendingDate
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". 2017-01-06
Owlstone Medical Ltd.. (1/6/17). "Press Release: Owlstone Medical Announces $11.55m USD Fundraising". Cambridge. 2017-01-06
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. 2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. 2017-01-05
HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. 2017-01-05
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. 2017-01-05
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. 2017-01-05
Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. 2017-01-05
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. 2017-01-05
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. 2017-01-05
Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. 2017-01-05
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Ablynx N.V.. (1/5/17). "Press Release: Ablynx to Present at the 35th J.P. Morgan Healthcare Conference". Ghent. 2017-01-05
Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. 2017-01-05
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. 2017-01-04
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. 2017-01-04
Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA. 2017-01-04
AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. 2017-01-04
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. 2017-01-04
Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. 2017-01-04
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. 2017-01-04
Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. 2017-01-04
Novimmune S.A.. (1/4/17). "Press Release: Novimmune Grants Tiziana an Exclusive License to NI-1201, an anti-IL-6R Monoclonal Antibody for the Treatment of Autoimmune and Inflammatory Diseases". Geneva. 2017-01-04
Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. 2017-01-04
Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. 2017-01-04
Bluebird Bio, Inc.. (1/4/17). "Press Release: Bluebird Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference". Cambridge, MA. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
InflaRx GmbH. (1/4/17). "Press Release: InflaRx Initiates Exploratory Phase II Trial with IFX-1, a First-in-class Anti-complement C5a Antibody, in Patients with Hidradenitis Suppurativa". Jena. 2017-01-04
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. 2017-01-04
Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. 2017-01-03
Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. 2017-01-03
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. 2017-01-03
SGS S.A.. (1/3/17). "Press Release: SGS Acquires Laboratoire LCA, Morocco". 2017-01-03
Pharnext S.A.. (1/3/17). "Press Release: Pharnext Announces the Amendment to the Liquidity Contract with French Broker Gilbert Dupont and the Annual Update on Its Liquidity Agreement". Paris. 2017-01-03
Intrexon Corporation. (1/3/17). "Press Release: Intrexon to Present at the 35th Annual J.P. Morgan Healthcare Conference". Germantown, MD. 2017-01-03
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. 2017-01-02
next pagenext page 1 2 3 ... 98 99 100



Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top